This question is basically six questions stapled together.
Structure your answer as a coherent pipeline: start with sequence representation and model choices, then detail the RL loop with reward design, and finish with evaluation and safety. Emphasize trade-offs and justify each design decision with respect to the target objective and biological constraints.
Pro tip: Highlight the importance of a well-calibrated reward function that balances multiple objectives (e.g., affinity and off-target effects) and mention using a held-out wet-lab validation set to avoid overfitting to the reward model.
Choose a representation (e.g., one-hot, k-mer, or learned embeddings) and select an LLM (e.g., DNABERT, Nucleotide Transformer) to generate or score sequences. Consider fine-tuning the LLM on relevant biological data.
Define a reward function that quantifies the target objective (e.g., predicted binding affinity from a surrogate model) and incorporates penalties for undesired properties (e.g., toxicity, off-target effects). Use a combination of learned and rule-based rewards.
Set up an RL loop where the LLM acts as the policy, generating sequences, and the reward function provides feedback. Use algorithms like PPO or REINFORCE with a baseline, and consider techniques like reward shaping and KL regularization to maintain sequence validity.
Evaluate generated sequences using in silico metrics (e.g., predicted affinity) and, if possible, wet-lab experiments. Use A/B testing to compare different RL configurations and iterate on the reward and model.
Address biosafety risks by filtering dangerous sequences, ensuring compliance with regulations, and incorporating human oversight. Discuss potential misuse and mitigation strategies.
AI-generated suggestions, not part of the candidate's original notes. May be inaccurate — verify before relying on them.